The goal of this activity is for learners to be better able to discuss and evaluate the mechanistic rationale and latest clinical data for the use of cardiac myosin inhibitor therapy in the evolving treatment landscape for hypertrophic cardiomyopathy.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/
- Start Date: 2025-01-24 06:00:00
- End Date: 2025-01-24 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.25 hours
Nursing: 1.25 hours
Pharmacy: 1.25 hours - MOC Credit Details: ABIM - 1.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Cytokinetics - Amount: 83663.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Advanced Heart Failure and Transplant Cardiology, Cardiovascular Disease
Subscribe
Login
0 Comments
Oldest